Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-30 7:31 pm Sale | 13D | RHYTHM PHARMACEUTICALS INC RYTM | NEW ENTERPRISE ASSOCIATES 13 LP | 0 0% | -92,909,956 (Position Closed) | View |
| 2024-04-17 4:15 pm Purchase | 13D | RHYTHM PHARMACEUTICALS INC RYTM | PERCEPTIVE ADVISORS LLC | 5,143,575 8.3% | 1,874,996 (+57.36%) | View |
| 2024-04-03 6:18 pm Unchanged | 13D | RHYTHM PHARMACEUTICALS INC RYTM | PERCEPTIVE ADVISORS LLC | 3,268,579 5.4% | 0 (Unchanged) | View |
| 2024-03-20 5:51 pm Purchase | 13D | RHYTHM PHARMACEUTICALS INC RYTM | PERCEPTIVE ADVISORS LLC | 3,268,579 5.4% | 8,566 (+0.26%) | View |
| 2024-02-14 5:01 pm Sale | 13G | RHYTHM PHARMACEUTICALS INC RYTM | RA CAPITAL MANAGEMENT L.P. | 5,330,412 9% | -185,655 (-3.37%) | View |
| 2024-02-14 4:21 pm Purchase | 13G | RHYTHM PHARMACEUTICALS INC RYTM | BAKER BROS. ADVISORS LP | 6,398,365 10.8% | 43,757 (+0.69%) | View |
| 2024-02-13 5:13 pm Purchase | 13G | RHYTHM PHARMACEUTICALS INC RYTM | VANGUARD GROUP INC | 3,226,938 5.46% | 3,226,938 (New Position) | View |
| 2024-02-12 4:16 pm Purchase | 13G | RHYTHM PHARMACEUTICALS INC RYTM | PERCEPTIVE ADVISORS LLC | 3,260,013 5.5% | 3,260,013 (New Position) | View |
| 2024-02-12 4:01 pm Purchase | 13G | RHYTHM PHARMACEUTICALS INC RYTM | PRIMECAP MANAGEMENT CO | 8,052,648 13.63% | 1,141,506 (+16.52%) | View |
| 2024-02-05 5:34 pm Sale | 13G | RHYTHM PHARMACEUTICALS INC RYTM | GOLDMAN SACHS GROUP INC GS | 4,998,761 8.5% | -202,499 (-3.89%) | View |
| 2024-01-24 09:46 am Purchase | 13G | RHYTHM PHARMACEUTICALS INC RYTM | BlackRock Inc. BLK | 6,351,750 10.7% | 86,745 (+1.38%) | View |
| 2024-01-23 09:04 am Sale | 13G | RHYTHM PHARMACEUTICALS INC RYTM | STATE STREET CORP STT | 2,206,018 3.73% | -974,680 (-30.64%) | View |
| 2023-09-07 10:14 am Sale | 13G | RHYTHM PHARMACEUTICALS INC RYTM | FEDERATED HERMES INC. FHI | 2,341,335 4.11% | -3,963,147 (-62.86%) | View |
| 2023-07-07 4:35 pm Purchase | 13G | RHYTHM PHARMACEUTICALS INC RYTM | BlackRock Inc. BLK | 6,265,005 11% | 2,541,291 (+68.25%) | View |
| 2023-03-28 6:51 pm Purchase | 13D | RHYTHM PHARMACEUTICALS INC RYTM | NEW ENTERPRISE ASSOCIATES 13 LP | 92,909,956 5.1% | 88,000,000 (+1792.28%) | View |
| 2023-02-14 4:45 pm Purchase | 13G | RHYTHM PHARMACEUTICALS INC RYTM | RA CAPITAL MANAGEMENT L.P. | 5,516,067 9.8% | 645,000 (+13.24%) | View |
| 2023-02-14 4:00 pm Purchase | 13G | RHYTHM PHARMACEUTICALS INC RYTM | BAKER BROS. ADVISORS LP | 6,354,608 11.3% | 291,906 (+4.81%) | View |
| 2023-02-09 4:01 pm Purchase | 13G | RHYTHM PHARMACEUTICALS INC RYTM | PRIMECAP MANAGEMENT CO | 6,911,142 12.27% | 654,151 (+10.45%) | View |
| 2023-02-09 12:01 pm Sale | 13G | RHYTHM PHARMACEUTICALS INC RYTM | JANUS HENDERSON GROUP PLC JHG | 1,240,153 2.2% | -1,893,782 (-60.43%) | View |
| 2023-02-07 6:12 pm Purchase | 13G | RHYTHM PHARMACEUTICALS INC RYTM | GOLDMAN SACHS GROUP INC GS | 5,201,260 9.2% | 2,143,701 (+70.11%) | View |